AI in Clinical Trials Market to Reach USD 2.7 Billion by 2035 | AI, Machine Learning & Decentralized Clinical Trials Drive Growth

➤ Market Overview

According to Market Genics, the AI in Clinical Trials Market is projected to grow from USD 1.1 Billion in 2025 to USD 2.7 Billion by 2035, registering a remarkable CAGR of 9.2% during the forecast period. The market is witnessing rapid expansion due to the increasing adoption of artificial intelligence (AI), machine learning (ML), predictive analytics, natural language processing (NLP), and automation across clinical research processes. AI technologies are transforming every stage of clinical trials-from patient recruitment and protocol design to site selection, data management, adverse event monitoring, and trial optimization. Rising R&D investments by pharmaceutical and biotechnology companies, increasing demand for decentralized clinical trials (DCTs), and the need to reduce drug development costs and timelines are key factors driving market growth. Additionally, regulatory support for digital transformation and the growing use of real-world evidence (RWE) are accelerating AI adoption in clinical research.

Get Free Sample PDF Brochure: https://marketgenics.co/download-report-sample/ai-in-clinical-trials-market-20004?utm_source=Open+pr&utm_medium=ruchika

➤ Growth Snapshot

The AI in Clinical Trials Market is experiencing significant momentum as sponsors and contract research organizations (CROs) leverage AI to improve trial efficiency, reduce patient dropout rates, and enhance data accuracy. AI-powered platforms enable faster patient identification using electronic health records (EHRs), optimize protocol design through predictive modeling, and improve clinical decision-making using advanced analytics. Increasing investments in cloud computing, AI-driven drug discovery, digital biomarkers, wearable technologies, and decentralized clinical trial platforms are expected to create lucrative growth opportunities throughout the forecast period. The growing collaboration between AI technology providers, pharmaceutical companies, and healthcare organizations further supports long-term market expansion.

➤ Market Key Players

• IQVIA Holdings Inc.
• Oracle Corporation
• Medidata Solutions (Dassault Systèmes)
• IBM Corporation
• Microsoft Corporation
• Google LLC
• SAS Institute Inc.
• Parexel International
• Thermo Fisher Scientific Inc.
• ICON plc
• Syneos Health
• Veeva Systems Inc.
• Medable Inc.
• Saama Technologies
• Clario

Buy Now Premium Research Report: https://marketgenics.co/buy/ai-in-clinical-trials-market-20004?utm_source=Open+pr&utm_medium=ruchika

➤ Market Segmentation

The AI in Clinical Trials Market is segmented based on component, deployment mode, technology, application, end user, and region. By component, the market includes software, services, and AI platforms. Based on deployment mode, the market is divided into cloud-based and on-premise solutions. By technology, the market comprises machine learning, deep learning, natural language processing (NLP), computer vision, predictive analytics, and robotic process automation (RPA). Applications include patient recruitment, protocol design, site selection, clinical data management, trial monitoring, pharmacovigilance, patient engagement, regulatory compliance, and trial analytics. End users include pharmaceutical companies, biotechnology firms, contract research organizations (CROs), academic research institutes, hospitals, and clinical research centers.

➤ Market Analysis and Insights

Artificial intelligence is fundamentally reshaping the clinical trials ecosystem by improving operational efficiency, reducing trial costs, and increasing the probability of successful outcomes. AI algorithms analyze vast volumes of clinical, genomic, and real-world data to identify suitable trial participants, predict patient responses, optimize trial protocols, and detect safety signals more efficiently than traditional methods. The increasing adoption of decentralized clinical trials, wearable devices, digital therapeutics, and remote patient monitoring is further expanding AI applications across the clinical research landscape. As regulatory agencies increasingly recognize AI-enabled approaches for clinical research optimization, organizations are expected to accelerate investments in intelligent clinical trial solutions. The market is also benefiting from rising collaborations between technology providers and life sciences companies to develop next-generation AI-powered research platforms.

➤ Segmentation and Targeting

The AI in Clinical Trials Market report is designed for pharmaceutical companies, biotechnology firms, contract research organizations (CROs), healthcare technology providers, AI software developers, clinical research organizations, hospitals, academic research institutions, regulatory agencies, investors, and life sciences companies. The report offers strategic insights for stakeholders involved in AI-powered clinical research, drug development, decentralized clinical trials, healthcare analytics, predictive modeling, precision medicine, regulatory technology (RegTech), and digital health innovation. It serves as a valuable resource for decision-makers seeking investment opportunities and competitive intelligence in the rapidly evolving clinical research market.

Browse In-depth Market Research Report: https://marketgenics.co/reports/ai-in-clinical-trials-market-20004?utm_source=Open+pr&utm_medium=ruchika

➤ Geographical Landscape

North America dominates the AI in Clinical Trials Market due to strong pharmaceutical R&D investments, advanced healthcare infrastructure, favorable regulatory frameworks, and widespread adoption of AI technologies across clinical research. The United States remains the largest contributor owing to the presence of leading pharmaceutical companies, AI technology providers, and CROs. Europe follows closely with significant investments in digital healthcare, clinical research modernization, and AI innovation across Germany, the United Kingdom, France, Switzerland, and the Netherlands. The Asia-Pacific region is projected to register the fastest CAGR during the forecast period, driven by expanding pharmaceutical manufacturing, increasing clinical trial activity, supportive government initiatives, and rising healthcare digitization in China, India, Japan, South Korea, Singapore, and Australia. Latin America and the Middle East & Africa are also emerging as promising markets due to increasing investments in healthcare infrastructure and clinical research capabilities.

➤ Questions Answered by the Report

• What is the current size of the AI in Clinical Trials Market?
• What will be the market value by 2035?
• What is the expected CAGR during 2025-2035?
• Which AI technologies are driving innovation in clinical trials?
• What are the major applications of AI across clinical research?
• Who are the leading companies operating in the AI in Clinical Trials Market?
• Which region dominates the market, and which region is expected to grow the fastest?
• What factors are driving the adoption of AI in clinical trials?
• What opportunities and challenges are shaping the future of the market?
• How will AI, predictive analytics, and decentralized clinical trials transform drug development over the next decade?

➤ Discover More Research Reports By MarketGenics:

Connected Ambulance Systems Market - https://www.openpr.com/news/4585511/connected-ambulance-systems-market-to-reach-usd-0-6-billion

Smart ICU Systems Market - https://www.openpr.com/news/4585515/smart-icu-systems-market-to-reach-usd-27-6-billion-by-2035-as-ai

AI-based Pathology Market - https://www.openpr.com/news/4585520/ai-based-pathology-market-to-reach-usd-0-8-billion-by-2035-as

Smart Implants Market - https://www.openpr.com/news/4585526/smart-implants-market-to-reach-usd-7-2-billion-by-2035-as-ai

AI in Hospital Operations Market - https://www.openpr.com/news/4585528/ai-in-hospital-operations-market-to-reach-usd-61-5-billion-by-2035

About MarketGenics

MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.

MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.

In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

This release was published on openPR.